Abstract
Primary immunodeficiencies (PIDs) are low-incidence diseases caused by defects in genes involved in the development, maintenance, and regulation of the immune system. Common variable immunodeficiency (CVID) is the most common symptomatic immunodeficiency of adulthood. It has an approximate prevalence of 1 in 25 000-50 000 in the general population, with a delay in diagnosis between 6-7 years. The clinical manifestations of CVID constitute 6 main categories: infections, pulmonary complications, granulomatous or polyclonal lymphocytic disease, autoimmunity, gastrointestinal diseases and malignancy. Most patients must have at least one of the following clinical manifestations (infection, autoimmunity, lymphoproliferation). However, the diagnosis of CVID can be conferred in asymptomatic patients, especially in familial cases. Secondary causes of hypogammaglobulinemia should be ruled out in any patient meeting the diagnostic criteria for CVID, as the treatment may be totally different from that required for CVID. Because CVID comprises a heterogeneous group of syndromes with poor primary antibody production, the potential number of entities within this group is unknown. Patients with CVID suffer from various complications that are considered prognostic. In the absence of clear guidelines for their search, it is recommended that lymphoproliferative disease, lung disease, liver disease and autoimmunity be investigated intentionally during the initial evaluation. The intervals in which they should be performed are not clear, but several evaluations may be required per year, according to the clinical evolution of the patient.
References
Adams N, Hoehndorf R, Gkoutos GV, Hansen G, Hennig C. PIDO: The primary immunodeficiency disease ontology. Bioinformatics. 2011;27(22):3193-3199. DOI: http://dx.doi.org/10.1093/bioinformatics/btr531
Ameratunga R, Woon ST, Gillis D, Koopmans W, Steele R. New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clin Exp Immunol. 2013;174(2):203-211. DOI: http://dx.doi.org/10.1111/cei.12178
Jolles S. The variable in common variable immunodeficiency: A disease of complex phenotypes. J Allergy Clin Immunol Pract. 2013;1(6):545-556. DOI: http://dx.doi.org/10.1016/j.jaip.2013.09.015
Sánchez LA, Maggadottir SM, Pantell MS, Lugar P, Rundles CC, Sullivan KE, et al. Two sides of the same coin: Pediatric-onset and adult-onset common variable immune deficiency. J Clin Immunol. 2017;37(6):592-602. DOI: http://dx.doi.org/10.1007/s10875-017-0415-5
Ameratunga R, Woon S, Gillis D, Koopmans W, Gillis D, Steele R. New diagnostic criteria for CVID. Expert Rev Clin Immunol. 2014;10(2):183-186.
Abbott JK, Gelfand EW. Common variable immunodeficiency: Diagnosis, management, and treatment. Immunol Allergy Clin North Am. 2015;35(4):637-658. DOI: http://dx.doi.org/10.1016/j.iac.2015.07.009
Ameratunga R, Brewerton M, Slade C, Jordan A, Gillis D, Steele R, et al. Comparison of diagnostic criteria for common variable immunodeficiency disorder. Front Immunol. 2014;5(415):1-9. DOI: http://dx.doi.org/10.3389/fimmu.2014.00415
Dong J, Liang H, Wen D, Wang J. Adult common variable immunodeficiency. Am J Med Sci. 2016;351(3):239-243. DOI: http://dx.doi.org/10.1016/j.amjms.2015.12.010
Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, De-la-Morena MT, et al. International Consensus Document (ICON): Common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4(1):38-59. DOI: http://dx.doi.org/10.1016/j.jaip.2015.07.025
Kumar Y, Bhatia A. Common variable immunodeficiency in adults: Current diagnostic protocol and laboratory measures. Expert Rev Clin Immunol. 2013; 9(10):959-977. DOI: http://dx.doi.org/10.1586/1744666X.2013.836967.
Baldovino S, Montin D, Martino S, Sciascia S, Menegatti E, Roccatello D. Common variable immunodeficiency: Crossroads between infections, inflammation and autoimmunity. Autoimmun Rev. 2013;12(8):796-801. DOI: http://dx.doi.org/10.1016/j.autrev.2012.11.003
Yazdani R, Seify R, Ganjalikhani-Hakemi M, Abolhassani H, Eskandari N, Golsaz-Shirazi F, et al. Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets. Allergol Immunopathol (Madr). 2017;45(2):183-192. DOI: http://dx.doi.org/10.1016/j.aller.2016.07.001
Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: Defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77-85. DOI: http://dx.doi.org/10.1182/blood-2007-06-091744
Abolhassani H, Sagvand BT, Shokuhfar T, Mirminachi B, Rezaei N, Aghamohammadi A. A review on guidelines for management and treatment of common variable immunodeficiency. Expert Rev Clin Immunol. 2013;9(6):561-574. DOI: http://dx.doi.org/10.1586/eci.13.30
Angulo-Pérez G, Vivar-Acevedo E, Herrera-Sánchez D. Identificación de microorganismos asociados con rinosinusitis crónica en pacientes adultos con inmunodeficiencia común variable. Rev Alerg México. 2016;63(1):26-31. Disponible en: http://revistaalergia.mx/ojs/index.php/ram/article/view/143/290
Jolles S. The variable in common variable immunodeficiency: A disease of complex phenotypes. J Allergy Clin Immunol Pract. 2013;1(6):545-556. DOI: http://dx.doi.org/10.1016/j.jaip.2013.09.015
López V, Rodríguez X, Olano C. Common variable immunodeficiency: Digestive involvement of a systemic disease. Acta Gastroenterol Latinoam. 2013;43(1):44-47.
Rodríguez-Negrete EV, Mayoral-Zavala A, Rodríguez-Mireles KA, De-León-Salazar OED, Hernández-Mondragón O, Gómez-Jiménez LM, et al. Prevalence of gastrointestinal disorders in adults with common variable immunodeficiency at specialty hospital Dr. Bernardo Sepulveda. Rev Alerg Mex. 2015;62(1):1-7.
Uzzan M, Ko HM, Mehandru S, Cunningham-Rundles C. Gastrointestinal disorders associated with common variable immune deficiency (CVID) and chronic granulomatous disease (CGD). Curr Gastroenterol Rep. 2016;18(4):17. DOI: http://dx.doi.org/10.1007/s11894-016-0491-3
Song J, Lleo A, Yang GX, Zhang W, Bowlus CL, Eric-Gershwin M, et al. Common variable immunodeficiency and liver involvement. Clin Rev Allergy Immunol. 2017. DOI: http://dx.doi.org/10.1007/s12016-017-8638-z
Nonas S. Pulmonary manifestations of primary immunodeficiency disorders. Immunol Allergy Clin North Am. 2015;35(4):753-766. DOI: http://dx.doi.org/10.1016/j.iac.2015.07.004
Hartono S, Motosue MS, Khan S, Rodriguez V, Iyer VN, Divekar R, et al. Predictors of granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency. Ann Allergy Asthma Immunol. 2017;118(5):614-620. DOI: http://dx.doi.org/10.1016/j.anai.2017.01.004
Human A, Murguia-Favela L, Benson L, Roifman I, Grunebaum E. Cardiovascular abnormalities in primary immunodeficiency diseases. LymphoSign J. 2015; 283):107-134. DOI: http://dx.doi.org/10.14785/lpsn-2014-0013
Cambray-Gutiérrez JC, Fernández-Muñoz MC, Del-Rivero-Hernández LG, López-Pérez P, Chávez-García A, Segura-Méndez NH. Cardiopatías estructurales y funcionales en pacientes adultos con inmunode ciencia común variable. Rev Alerg Mex. 2015;62(2):91-97. Disponible en: http://revistaalergia.mx/ojs/index.php/ram/article/view/69/139
Azizi G, Abolhassani H, Asgardoon MH, Alinia T, Yazdani R, Mohammadi J, et al. Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management. Expert Rev Clin Immunol. 2017;13(2):101-115. DOI: http://dx.doi.org/10.1080/1744666X.2016.1224664
O’Farrill-Romanillos PM, Campos-Romero FH, Mendoza-Reyna LD, Amaya-Mejía AS, Galindo-Pacheco LV, González-Virla B, et al. Enfermedades hematológicas autoinmunes en adultos con inmunodeficiencia común variable. Rev Alerg Mex. 2012;59(4):187-191.
Xiao X, Miao Q, Chang C, Gershwin ME, Ma X. Common variable immunodeficiency and autoimmunity-an inconvenient truth. Autoimmun Rev. 2014;13(8):858-864. DOI: http://dx.doi.org/10.1016/j.autrev.2014.04.006
Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650-1657. DOI: http://dx.doi.org/10.1182/blood-2011-09-377945
Ardeniz Ö, Cunningham-Rundles C. Granulomtous disease in common variable immunodeficiency. Clin Immunol. 2009;133(2):198-207. DOI: http://dx.doi.org/10.1016/j.clim.2009.05.001
Arnold DF, Wiggins J, Cunningham-Rundles C, Misbah SA, Chapel HM. Granulomatous disease: distinguishing primary antibody disease from sarcoidosis. Clin Immunol. 2008;128(1):18-22. DOI: http://dx.doi.org/10.1016/j.clim.2008.03.510
López-Rocha E, Rodríguez-Mireles K, Segura-Méndez NH, Yamazaki-Nakashimada MA. Malignancies in adult patients with common variable immunodeficiency. Rev Alerg Mex. 2015;62(1):22-27.
Cambray-Gutiérrez JC, Herrera-Sánchez DA, Blancas-Galicia L, O’Farrill-Romanillos PM. Clínica de inmunodeficiencias primarias en adultos. Experiencia en un hospital de tercer nivel. Rev Alerg Mex. 2016;63(4):334-341. Disponible en: http://revistaalergia.mx/ojs/index.php/ram/article/view/171/379
Nguyen JT-U, Green A, Wilson MR, DeRisi JL, Gundling K. Neurologic complications of common variable immunodeficiency. J Clin Immunol. J Clin Immunol. 2016;36(8):793-800. DOI: http://dx.doi.org/10.1007/s10875-016-0336-8
Condino-Neto A, Costa-Carvalho BT, Grumach AS, King A, Bezrodnik L, Oleastro M, et al. Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America. Allergol Immunopathol (Madr). 2014;42(3):245-260. DOI: http://dx.doi.org/10.1016/j.aller.2012.09.006
Hodkinson JP. Considerations for dosing immunoglobulin in obese patients. Clin Exp Immunol. 2017;188(3):353-362. DOI: http://dx.doi.org/10.1111/cei.12955
Rodríguez-Mireles KA, Galguera-Sauceda A, Gaspar-López A, López-Rocha EG, Campos-Romero FH, Del-Rivero-Hernández LG, et al. Efectos adversos de la aplicación ambulatoria de inmunoglobulina intravenosa en adultos con inmunodeficiencia común variable. Rev Alerg Mex. 2014;61(3):131-140. Disponible en: http://revistaalergia.mx/ojs/index.php/ram/article/view/37
Bonilla FA. Intravenous immunoglobulin: Adverse reactions and management. J Allergy Clin Immunol. 2008;122(6):1238-1239. DOI: http://dx.doi.org/10.1016/j.jaci.2008.08.033
Berger M. Adverse effects of IgG therapy. J Allergy Clin Immunol Pract. 2013;1(6):558-566. DOI: http://dx.doi.org/10.1016/j.jaip.2013.09.012
Cantú T, Hoehn-Saric E, Burgess KM, Racusen L, Scheel PJ. Acute renal failure associated with immunoglobulin therapy. Am J Kidnay Dis. 1995;25(2):228-234. DOI: http://dx.doi.org/10.1016/0272-6386(95)90003-9
Zhang R, Szerlip HM. Reemergence of sucrose nephropathy: Acute renal failure caused by high-dose intravenous immune globulin therapy. South Med J. South Med J. 2000;93(9):901-904. DOI: http://dx.doi.org/10.1097/00007611-200093090-00013
Rizzi M, Neumann C, Fielding AK, Marks R, Goldacker S, Thaventhiran J, et al. Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency. J Allergy Clin Immunol. 2011;128(6):1371-1374. DOI: http://dx.doi.org/10.1016/j.jaci.2011.07.055
Wehr C, Gennery AR, Lindemans C, Schulz A, Hoenig M, Marks R, et al. Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency. J Allergy Clin Immunol. 2015;135(4):988-997. DOI: http://dx.doi.org/10.1016/j.jaci.2014.11.02

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2017 Revista Alergia México